TORRENT PHARMACEUTICALS LIMITED Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 2.690 INR | -0,07% |
|
+6,05% | +16,72% |
Totale waarde
| Fiscaal tijdperk: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 330.355 | 333.623 | 430.029 | 473.197 | 520.309 | 910.571 | - | - |
| Bedrijfswaarde 1 | 366.505 | 387.633 | 458.139 | 508.027 | 566.719 | 947.733 | 935.831 | 920.943 |
| K/w-verhouding | 75,7 x | 32,6 x | 34,3 x | 60,9 x | 57,4 x | 56,1 x | 44,3 x | 35,7 x |
| Dividendrendement | 0,87% | 0,86% | 1,38% | 1,18% | 1,43% | 0,8% | 0,9% | 0,98% |
| Marktkapitalisatie/omzet | 4,31 x | 4,2 x | 5,37 x | 5,56 x | 5,41 x | 8,42 x | 7,47 x | 6,63 x |
| Bedrijfswaarde/omzet | 4,78 x | 4,88 x | 5,72 x | 5,97 x | 5,89 x | 8,76 x | 7,67 x | 6,71 x |
| Bedrijfswaarde/EBITDA | 18,5 x | 17,9 x | 18,4 x | 20,9 x | 19,9 x | 28,1 x | 23,9 x | 20,3 x |
| Bedrijfswaarde/FCF | 32,3 x | 39,3 x | 27,3 x | 31,8 x | 31,6 x | 43,2 x | 38,7 x | 32,6 x |
| FCF Yield | 3,1% | 2,54% | 3,66% | 3,15% | 3,17% | 2,32% | 2,58% | 3,07% |
| Price to Book | 6,99 x | 6,92 x | 7,4 x | 7,95 x | 8,4 x | 12,7 x | 10,9 x | 9,1 x |
| Aantal aandelen (in duizenden) | 338.444 | 338.445 | 338.445 | 338.445 | 338.445 | 338.445 | - | - |
| Referentieprijs 2 | 976,1 | 985,8 | 1.271 | 1.398 | 1.537 | 2.690 | 2.690 | 2.690 |
| Datum van publicatie | 20/05/19 | 26/05/20 | 18/05/21 | 25/05/22 | 30/05/23 | - | - | - |
1INR in Miljoen2INR
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 76.730 | 79.390 | 80.050 | 85.080 | 96.200 | 108.151 | 121.959 | 137.315 |
| EBITDA 1 | 19.840 | 21.700 | 24.850 | 24.310 | 28.420 | 33.777 | 39.156 | 45.355 |
| Bedrijfsresultaat (EBIT) 1 | 13.660 | 15.160 | 18.270 | 17.690 | 21.350 | 25.730 | 30.773 | 36.743 |
| Operationele Marge | 17,8% | 19,1% | 22,82% | 20,79% | 22,19% | 23,79% | 25,23% | 26,76% |
| Resultaat voor belastingen (EBT) 1 | 5.620 | 11.870 | 15.260 | 12.260 | 18.470 | 23.149 | 29.054 | 35.784 |
| Nettowinst (verlies) 1 | 4.360 | 10.250 | 12.520 | 7.770 | 12.450 | 16.431 | 20.552 | 25.454 |
| Nettomarge | 5,68% | 12,91% | 15,64% | 9,13% | 12,94% | 15,19% | 16,85% | 18,54% |
| WPA 2 | 12,89 | 30,28 | 36,99 | 22,96 | 26,79 | 48,00 | 60,74 | 75,29 |
| Free Cash Flow 1 | 11.352 | 9.860 | 16.760 | 16.000 | 17.940 | 21.949 | 24.181 | 28.269 |
| FCF-marge | 14,8% | 12,42% | 20,94% | 18,81% | 18,65% | 20,29% | 19,83% | 20,59% |
| Kasstroomconversie (ebitda) | 57,22% | 45,44% | 67,44% | 65,82% | 63,12% | 64,98% | 61,75% | 62,33% |
| Kasstroomconversie (nettowinst) | 260,38% | 96,2% | 133,87% | 205,92% | 144,1% | 133,58% | 117,65% | 111,06% |
| Dividend per aandeel 2 | 8,500 | 8,500 | 17,50 | 16,50 | 22,00 | 21,53 | 24,13 | 26,46 |
| Datum van publicatie | 20/05/19 | 26/05/20 | 18/05/21 | 25/05/22 | 30/05/23 | - | - | - |
1INR in Miljoen2INR
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Marzo | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 19.950 | 19.370 | 21.340 | 21.370 | 21.080 | 21.310 | 23.470 | 22.910 | 24.910 | 24.910 | 25.910 | 26.329 | 27.505 | 27.836 | 29.472 |
| EBITDA 1 | 6.070 | 5.820 | 6.770 | 6.600 | 5.380 | 5.610 | 7.120 | 6.790 | 7.240 | 7.270 | 7.910 | 8.124 | 8.597 | 8.895 | - |
| Bedrijfsresultaat (EBIT) 1 | 4.400 | 4.170 | 5.120 | 4.920 | 3.710 | 3.990 | 5.570 | 5.160 | 5.310 | 5.310 | 6.000 | 6.087 | 6.507 | 6.782 | 7.165 |
| Operationele Marge | 22,06% | 21,53% | 23,99% | 23,02% | 17,6% | 18,72% | 23,73% | 22,52% | 21,32% | 21,32% | 23,16% | 23,12% | 23,66% | 24,37% | 24,31% |
| Resultaat voor belastingen (EBT) 1 | 3.570 | 3.830 | 4.840 | 4.720 | 3.570 | -870 | 5.320 | 4.630 | 4.190 | 4.330 | 5.310 | 5.592 | 6.014 | 6.426 | - |
| Nettowinst (verlies) 1 | 2.970 | 3.240 | 3.300 | 3.160 | 2.490 | -1.180 | 3.540 | 3.120 | 2.830 | 2.870 | 3.780 | 3.892 | 4.173 | 4.570 | - |
| Nettomarge | 14,89% | 16,73% | 15,46% | 14,79% | 11,81% | -5,54% | 15,08% | 13,62% | 11,36% | 11,52% | 14,59% | 14,78% | 15,17% | 16,42% | - |
| WPA 2 | 8,760 | 9,580 | 9,765 | 9,315 | 7,375 | -3,490 | 20,90 | 9,220 | 8,360 | 8,480 | 11,18 | 11,43 | 12,51 | 13,23 | - |
| Dividend per aandeel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 8/02/21 | 18/05/21 | 27/07/21 | 26/10/21 | 25/01/22 | 25/05/22 | 29/07/22 | 21/10/22 | 25/01/23 | 30/05/23 | 7/08/23 | - | - | - | - |
1INR in Miljoen2INR
Geschatte gegevens
Balans
| Fiscaal tijdperk: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 36.150 | 54.010 | 28.110 | 34.830 | 46.410 | 37.163 | 25.261 | 10.372 |
| Nettokaspositie 1 | - | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 1,822 x | 2,489 x | 1,131 x | 1,433 x | 1,633 x | 1,1 x | 0,6451 x | 0,2287 x |
| Free Cash Flow 1 | 11.353 | 9.860 | 16.760 | 16.000 | 17.940 | 21.949 | 24.181 | 28.269 |
| ROE (netto-inkomsten/eigen vermogen) | 15,4% | 21,5% | 23,5% | 13,2% | 20,5% | 24,2% | 26,9% | 28,4% |
| ROA (netto-inkomsten/totale activa) | 5,06% | 7,28% | 8,92% | 5,72% | 8,86% | 11,2% | 13,3% | 15,4% |
| Totale activa 1 | 86.166 | 140.795 | 140.425 | 135.875 | 140.560 | 147.350 | 154.743 | 165.299 |
| Nettoactief per aandeel 2 | 140,0 | 142,0 | 172,0 | 176,0 | 183,0 | 213,0 | 247,0 | 296,0 |
| Cashflow per aandeel 2 | 53,20 | 41,10 | 59,40 | 53,30 | 51,00 | 63,60 | 69,10 | 78,60 |
| Capex 1 | 6.628 | 4.060 | 3.350 | 2.030 | 5.740 | 3.488 | 3.477 | 3.575 |
| Capex/omzet | 8,64% | 5,11% | 4,18% | 2,39% | 5,97% | 3,22% | 2,85% | 2,6% |
| Datum van publicatie | 20/05/19 | 26/05/20 | 18/05/21 | 25/05/22 | 30/05/23 | - | - | - |
1INR in Miljoen2INR
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
29
Laatste slotkoers
2.690
INR
Gemiddelde koersdoel
2.729
INR
Spread / Gemiddelde doel
+1,43%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +16,72% | 10,92 mld. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers TORNTPHARM
- Financiën Torrent Pharmaceuticals Limited
